03.05.2024  22:10:00 Zm. -1,26 Wolumen Bid02:00:00 Ask02:00:00 Kapitalizacja Rynkowa St. dywidendy Wskaźnik C/Z
70,00USD -1,77% 223 436
Obrót: 9,55 mln
68,08Wolumen Bid: 100 72,07Wolumen Ask: 100 3,48 mldUSD - -

Opis działalności

Prestige Consumer Healthcare, Inc. markets and distributes brand name over-the-counter healthcare products throughout the U.S. and Canada, Australia, and in certain other international markets. The Company’s brands include Monistat® and Summer’s Eve® women's health products, BC® and Goody's® pain relievers, Clear Eyes® eye care products, DenTek® and The Doctor's® oral care products, Dramamine® motion sickness treatments, Fleet® enemas and glycerin suppositories, Chloraseptic® sore throat treatments, Compound W® wart treatments, Little Remedies® pediatric over-the-counter products, Efferdent® denture care products, Luden's® throat drops, Debrox® earwax remover, Gaviscon® antacid in Canada, and Hydralyte® rehydration products and the Fess® line of nasal and sinus care products in Australia.
 

Zarząd & Rada nadzorcza

CEO
Ron Lombardi
Zarząd
Christine Sacco, Adel Mekhail, Jeff Thompson, Jeff Zerillo, Mary Beth Fritz, William P'Pool
Rada nadzorcza
Ron Lombardi, Christopher J. Coughlin, Dawn M. Zier, Dr. Celeste A. Clark, Dr. Gary E. Costley, James M. Jenness, John E. Byom, Natale S. Ricciardi, Sheila A. Hopkins
 

Dane firmy

Nazwa: Prestige Consumer Healthcare, Inc.
Adres: 660 White Plains Road,Tarrytown, New York 10591, USA
Telefon: +1-914-524-6800
Fax: -
E-mail: Irinquiries@prestigebrands.com
Internet: www.prestigebrandsinc.com/
Przemysł: Dobra konsumpcyjne
Sektor: Kosmetyki
Podsektor: Kosmetyki
Koniec roku finansowego: 31.03
Free float: 69,88%
Data IPO: -

Relacje inwestorskie

Nazwa: Phil Terpolilli
Telefon: +1-914-524-6819
Fax: -
E-mail: -

Główni akcjonariusze

Freefloat
 
69,88%
BlackRock, Inc.
 
12,50%
The Vanguard Group
 
10,72%
Dimensional Fund Advisors LP
 
6,90%